T1	Disorder 10 19	Arthritis
N1 	Reference T1 UMLS:C0003864	Arthritis
T2	Disorder 24 32	bursitis
N2 	Reference T2 UMLS:C0006444	bursitis
T3	Disorder 36 54	multiple sclerosis
N3 	Reference T3 UMLS:C0026769	multiple sclerosis
T6	Pharmacological_substance 95 110	Interferon-beta
N1000 	Reference T6 MeSH:D016899	Interferon-beta
T9	Pharmacological_substance 112 120	IFN-beta
N1001 	Reference T9 MeSH:D016899	IFN-beta
T11	Pharmacological_substance 127 144	type I interferon
N1002 	Reference T11 MeSH:D007370	type I interferon
N1003 	Reference T11 MeSH:D007372	type I interferon
T12	Disorder 171 189	multiple sclerosis
N4 	Reference T12 UMLS:C0026769	multiple sclerosis
T13	Pharmacological_substance 204 212	IFN-beta
N1004 	Reference T13 MeSH:D016899	IFN-beta
T16	Disorder 264 284	autoimmune disorders
N5 	Reference T16 UMLS:C0004364	autoimmune disorders
T17	Disorder 345 383	relapsing-remitting multiple sclerosis
N6 	Reference T17 UMLS:C0751967	relapsing-remitting multiple sclerosis
T20	Pharmacological_substance 460 468	IFN-beta
N1005 	Reference T20 MeSH:D016899	IFN-beta
T21	Pharmacological_substance 550 558	IFN-beta
N1006 	Reference T21 MeSH:D016899	IFN-beta
T24	Disorder 695 721	autoimmune thyroid disease
T25	Disorder 728 760	refractory pre-patellar bursitis
N7 	Reference T25 UMLS:C2919248	refractory pre-patellar bursitis
T26	Pharmacological_substance 780 788	IFN-beta
N1007 	Reference T26 MeSH:D016899	IFN-beta
T29	Disorder 865 887	inflammatory arthritis
N8 	Reference T29 UMLS:C0003864	inflammatory arthritis
T30	Disorder 891 893	MS
N9 	Reference T30 UMLS:C0026269	MS
N10 	Reference T30 UMLS:C0026769	MS
T31	Pharmacological_substance 913 921	IFN-beta
N1008 	Reference T31 MeSH:D016899	IFN-beta
T34	Pharmacological_substance 993 1001	IFN-beta
N1009 	Reference T34 MeSH:D016899	IFN-beta
T37	Disorder 1005 1041	inflammatory musculoskeletal disease
N11 	Reference T37 UMLS:C0026857	inflammatory musculoskeletal disease
T4	Pharmacological_substance 77 92	interferon-beta
N1010 	Reference T4 MeSH:D016899	interferon-beta
T14	Manner_cue 217 223	rarely
T15	Subject 310 329	two female patients
T19	Disorder 385 389	RRMS
N12 	Reference T19 UMLS:C0751967	RRMS
T22	Disorder 508 521	monoarthritis
N13 	Reference T22 UMLS:C0158026	monoarthritis
T35	Subject 970 979	two cases
T38	Coreferring_mention 1096 1118	this therapeutic agent
T39	Disorder 1068 1092	autoimmune complications
T40	Speculation_cue 1058 1067	potential
T41	Coreferring_mention 482 495	first patient
T42	Coreferring_mention 665 679	second patient
T43	Disorder 405 448	inflammatory musculoskeletal manifestations
T46	Speculation_cue 1045 1052	unclear
T47	Subject 843 846;894 902	six patients
T48	Subject 55 63	patients
